[SYRE] QoQ Quarter Result on 31-Mar-2015 [#Q1]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Mar-2015
Financial Year
2015
Quarter
31-Mar-2015 [#Q1]
Profit Trend
QoQ- 22.41%
YoY- -62.37%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Revenue 1,585 1,073 3,427 0 0 0 0 -
PBT -3,987 -3,413 -1,427 -2,468 -3,181 -3,250 -2,396 40.29%
Tax 0 0 0 0 0 0 0 -
NP -3,987 -3,413 -1,427 -2,468 -3,181 -3,250 -2,396 40.29%
Tax Rate - - - - - - - -
Total Cost 5,572 4,486 4,854 2,468 3,181 3,250 2,396 75.25%
Ratio Analysis
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
NP Margin -251.55 -318.08 -41.64 0.00 0.00 0.00 0.00 -
Per Share
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
EPS 0.00 -12.51 -5.23 -9.88 0.00 0.00 0.00 -
EPS Diluted 0.00 -12.51 -5.23 -9.88 0.00 0.00 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.